Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Chromocell Therapeutics Corp ( (CHRO) ) just unveiled an update.
Channel Therapeutics Corporation, formerly Chromocell Therapeutics, has rebranded and reincorporated to emphasize its focus on non-opioid pain treatments using sodium channel modulation. The company is advancing its therapeutic programs, including eye pain and depot programs, with efficacy results anticipated soon. This strategic move is aimed at enhancing growth, valuation, and tax benefits.
Find detailed analytics on CHRO stock on TipRanks’ Stock Analysis page.
